An interview with PLOS ONE Pediatric Section Editors Ju-Lee Oei and Ivan Florez

In this interview we speak with PLOS ONE Pediatric Section Editors Professor Ju-Lee Oei and Professor Ivan Florez. Here they discusses their important research and work with PLOS ONE. 

Image courtesy of Ju-Lee Oei

Ju-Lee Oei is a Neonatologist at the Royal Hospital for Women, Randwick; Conjoint Professor at UNSW Sydney; and Honorary Associate Professor at the NHMRC Clinical Trials Centre, University of Sydney. Her work focuses on the care of sick newborn infants, especially those with Neonatal Abstinence Syndrome (NAS)/perinatal substance use and infants requiring neonatal intensive care. A particular interest of hers is the use of oxygen in newborn delivery room resuscitation. She has an extensive collaborative network with researchers, clinicians and policy makers from Australia as well as overseas in more than 20 universities and 10 countries. She is also currently Visiting Professor to the University of Malaya and the North West Children’s Hospital and University of China. She also contributed to state and national guidelines for management of neonatal abstinence syndrome as well as guidelines for the American Breast Feeding Medical Association for maternal drug use.

Image credit

Courtesy of Ivan Florez

Ivan Florez is a Associate Professor at University of Antioquia and Assistant Professor at McMaster University. He is also a pediatrician at Clinica Las Américas AUNA with a Master in Clinical Epidemiology and a Ph.D. in Health Research Methodology. He also acts as the leader of the AGREE Collaboration and Director of Cochane Colombia. His research is focused on Evidence-Based Pediatrics, Knowledge translation, Systematic Reviews, network Meta-analysis, Clinical Practice Guidelines and the use of Evidence in all the levels of the Health Care Systems.

Why did you choose to enter pediatric research?  What do you like most about your field?

JU-LEE OEI: Keeps me from being bored! Serious answer: the most worthwhile thing about research is plugging in gaps in practice and knowledge and generating curiosity that really, is the driver of medical advances.

IVAN FLOREZ: I am a physician, I finished my Pediatric residency in 2006, and around 2008 I decided I wanted to do clinical research in my field. I found that there was a need for me as a Clinician to identify and try to answer urgent questions that I found in my clinical work

You have recently become our new Section Editors for Pediatrics. Why did you decide to join our Editorial Board and what motivates you about your new role?

JU-LEE OEI: A chance to draw attention to what the knowledge needs that will advance and improve child health.

IVAN FLOREZ: I have been the Academic Editor of PLOS ONE since 2018. Interestingly, I decided to be an Academic editor after I published my first paper in PLOS ONE, and after I reviewed several papers as a peer reviewer. I strongly advocate for Open Access, and I think PLOS ONE is one of the pioneers in Open Science. So why not join PLOS ONE and contribute to making better open-access science?

What do you think is the most exciting area in Pediatric research at the moment?

JU-LEE OEI: Personalized medicine – one size does not fit all!

IVAN FLOREZ: I think neonatology is the hottest topic field in pediatrics, followed by infectious diseases (including vaccines, antibiotic treatments, resistance and viral infections). Both are vibrant fields in which a lot of research is going on. COVID19 pandemic helped in increasing awareness about the ID field, and the neonatology field has been a key area for decades and will continue to be so as well. 

What are, in your opinion, the most important challenges for the Pediatric research community?

JU-LEE OEI: Addressing entrenched practices and lack of equipoise for interventions that have no evidence for benefit.

IVAN FLOREZ: I think the pediatric field has always been behind compared to adult clinical research for many reasons, including ethical  concerns. But, I think the gap between the two has been shrinking. In the last decade, clinical research in pediatrics has expanded, and more scholars are interested in this field. Some interesting fields are related such as mental health and also sexual and gender diversity, which had been neglected in the past, but they are gaining the space they deserve, and more and more research in these fields will be coming in the near future.

How important is Open Science for the Pediatric research community? What role can PLOS ONE play to contribute to Pediatric research?

JU-LEE OEI: Extremely  – many authors do not have access to paid journals and PLOS ONE allows free and equitable access to high level science. However, this needs to remain high level since many open access journals continue to publish manuscripts of questionable value.

IVAN FLOREZ: It is essential. We need Open science for all, and to reduce inequities, we need to encourage it. Pediatrics needs it even more than many other fields because most of the burden in pediatrics is in LMIC and by providing open science, we are facilitating access to knowledge without paywalls, and borders. This definitely reduces the gaps in child care across the world. 

Why would you advise authors to publish in PLOS ONE?

JU-LEE OEI: High impact, equitable access, rapid turn around!

IVAN FLOREZ: A very efficient and transparent publication process, with some of the lowest times between submission and publication. We make an effort in finding the best peer reviewers for the submitted paper. 

PLOS ONE is interested in very exciting papers in any pediatric-related field. 

Disclaimer: Views expressed by contributors are solely those of individual contributors, and not necessarily those of PLOS.

The post An interview with PLOS ONE Pediatric Section Editors Ju-Lee Oei and Ivan Florez appeared first on EveryONE.

An interview with PLOS ONE Women’s and Maternal Health Section Editor Rubeena Zakar

In this interview we speak with Rubeena Zakar PLOS ONE’s new section editor for Women’s and Maternal health. Here she discusses her important research and work with PLOS ONE. Dr. Rubeena Zakar is currently professor of Public Health and Director of the Institute of Social and Cultural Studies, University of the Punjab, Lahore, Pakistan. She earned her Bachelor of Medicine and Bachelor of Surgery (MBBS) from Sindh Medical College, Karachi University, Master’s in Population Sciences from Punjab University (2006); and Ph.D in Public Health from Bielefeld University, Germany (2012) with distinction (Summa cum laude).
Her research interests include gender-based violence, women’s health in developing countries, maternal and child health, inequalities in health care utilization, health and human rights, and gender and development. 

Why did you choose to enter Women’s health research?  What do you like most about your field? 

RZ: By training, I am a medical doctor. While I was doing my residency in Gynecology and Obstetrics, many a times I met with women who experienced violence and had sexual and reproductive health issues such as unplanned pregnancy due to violence. Having the thrust for research on maternal and child health since the third year of my medical education, this close interaction with women triggered me to do research in this area.  

For the last 20 years, I have been involved in a wide range of research activities focusing on women’s health, empowerment and enhancement of their social status and economic participation. My 80 plus publications in impact factor international journals mainly highlight women’s health and child health related issues. The central themes and primary focus of my research is that women’s meaningful participation is the key driver of country’s socio-economic development trajectories.  

As a Professor of Public Health, I have been assembling evidence to demonstrate that gender issues are critically important for Pakistani society. Getting inspiration from Robert K. Merton’s notion that ‘data has power’, I have been presenting empirical evidence to suggest that lack of investment in women’s health has serious negative implications on country’s economy, polity and global reputation. My research has also illuminated that if women are victims of violence, ignorance and social exclusion, country cannot attain economic prosperity, peace, stability and social harmony. 

My research on social epidemiology, infectious diseases (such as dengue and Covid-19), on child health such as breastfeeding practices,  child nutrition & Vitamin D deficiency have documented that social and health scientist must come forward to present out-of-the-box solutions to deal with social determinants of health instead of over-investing on hospital-based curative techniques.  

You have recently become our new Section Editor for Women’s health. Why did you decide to join our Editorial Board and what motivates you about your new role? 

RZ: I like my role as section editor for women’s health, as women’s health especially in LMICs is very close to my heart. As a section editor, I get to know new research in this area from different part of the world as it comes out. It helps me to understand and see the strengths and weaknesses of researches from all over the world. I am confident that my contributions as section editor will leave a positive mark in this area through reflecting high-quality work in this area. It helps me to get familiarity with ongoing research in women’s health, give me institutional credit, and above all gives me greater visibility within my research community which motivated me to work as Editorial Board Member.  

What do you think is the most exciting area in Women’s health research at the moment? 

RZ: Social determinants greatly affect women’s health particularly in developing countries. In some parts of the world, women are deprived of their basic rights including access to health services, appropriate nutrition and education. Socio-cultural practices such as child marriages, forced marriages, cousin marriages, female genital mutilation, and son preference undermine women health and wellbeing.  Additionally, various negative stereotypes such as pregnancy and childbirth related taboos, dowry and honor related violence, restrictions on women’s mobility and social participation are significantly associated with women’s health status. For improving women’s sexual and reproductive health, society needs to take comprehensive and integrated measures to address the cultural stereotypes and harmful sociocultural practices against women. 

What are, in your opinion, the most important challenges for the Women’s health research community? 

RZ: Still in many parts of the world, particularly in conservative areas, talking about women’s health, especially related to social issues, is considered a western agenda. Most of the research on women’s health is focusing on mortality and morbidity around maternal health and life course perspective is still lacking in this area. There is lack of adequately trained researchers in this field. In many countries, nationally representative data is not available on women’s health issues which lead to lack of evidence-based policies, planning and programs. And the results derived from local studies are rarely available to wider audience and are not widely circulated.  

How important is Open Science for the Women’s health research community? What role can PLOS ONE play to contribute to Women’s health research? 

RZ: Open Science for women’s health research community is very important to disseminate and share knowledge from all over the world especially for the researchers from low- and middle-income countries.  PLOS One is playing its great role by sharing and disseminating scholarship in women’s health with women’s health researchers’ community. In PLOS One, there is great representation of research on different issues related to women’s health from different countries across the globe. 

Why would you advise authors to publish in PLOS ONE? 

RZ: There are many valid reasons to advice authors to publish in PLOS One. I am sharing some points below: 

  • PLOS One is highly reputable journal in the field of Public Health with high impact factor. Journal’s citation and readership is spread all over the world.  
  • The process of manuscript review and feedback is very rigorous. The reviewers provide their detailed constructive feedback in timely manner, which helps to improve the research and writing skills of authors.  
  • Being a well-known journal in the field, publishing with PLOS One helps the authors to increase their visibility with relevant influencers.  
  • PLOS One also provides the opportunity to their authors to be a part of peer-review process for their manuscripts. To me, to be a reviewer is a win-win situation which helps the authors to learn new research from different perspectives.  
Image credit Courtesy of Rubeena Zuakr

Disclaimer: Views expressed by contributors are solely those of individual contributors, and not necessarily those of PLOS

The post An interview with PLOS ONE Women’s and Maternal Health Section Editor Rubeena Zakar appeared first on EveryONE.

Partnership at the heart of PLOS ONE: The Role of Academic Editors

From its inception, PLOS ONE’s mission has been clear: to create an inclusive venue for all rigorous scientific research irrespective of its perceived impact. Moreover, PLOS wanted to create a journal for, and run by,